Ask your doctor about Sogroya®, the first and only once‐weekly growth hormone treatment approved for GHD and 3 other specific pediatric growth‐related conditions.
Sogroya® is given by injection under the skin and is used to treat adults who do not make enough growth hormone and children 2.5 years of age and older who: are not growing because of low or no growth hormone, are short (in stature) and were born small (Small for Gestational Age-SGA) and have not caught up in growth by age 2 years, are not growing and have Noonan Syndrome (NS), and have Idiopathic Short Stature (ISS).
Important Safety Information
Important Safety Information Continued